Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
2.74%
↑ 119% vs avg
Percentile
P80
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-14.55%
Historical baseline
PeriodValue
20252.74%
2024-10.05%
2023-54.64%
2022-51.65%
202126.27%
20200.00%